HALO AP

Indica Labs’ Bay Area HALO® User Group Meeting 2025

21 October 2025 | Indica Labs is pleased to announce our Bay Area HALO® User Group Meeting at The Lighthouse Café & Conference Center on 21 October from 10:00am – 3:30pm. Lunch will be provided to all pre-registered attendees at 12:20pm.

Indica Labs’ Bay Area HALO® User Group Meeting 2025 Read More »

Indica Labs' HER2 low and ultralow UI

Low and Ultralow HER2 Expression in Breast Cancer is Now Detectable by Indica Labs’ Breast IHC AI

Albuquerque, NM, April 30, 2025 – Indica Labs, the leading provider of AI-powered digital pathology solutions, announces today an update to their Breast IHC AI suite, an image analysis tool used for the quantification of HER2, ER, PR, and Ki67 within AI-identified, tumor regions, of breast cancer tissue specimens. The HER2 algorithm will now include functionality for the detection of low and ultralow HER2 expression in breast cancer.

Low and Ultralow HER2 Expression in Breast Cancer is Now Detectable by Indica Labs’ Breast IHC AI Read More »

Indica Labs Expands their Macrodissection Suite with the Launch of CRC Macrodissect AI

Indica Labs, the leading provider of AI-powered digital pathology solutions, announces today the expansion of their macrodissection suite with the launch of CRC Macrodissect AI.

Indica Labs Expands their Macrodissection Suite with the Launch of CRC Macrodissect AI Read More »

Open Pathology and AI Integrations: Empowering Labs with Choice

In digital pathology, advancements and proliferation in artificial intelligence (AI) and digital laboratory equipment are enabling streamlined workflows and new insights. However, they can also multiply the potential challenges laboratories face with software integration.

Open Pathology and AI Integrations: Empowering Labs with Choice Read More »

CRC Macrodissect AI and Breast HER2 AI Sneak Peek

27 March 2025 | Learn about the latest advancements in AI-powered pathology. In this webinar, we’ll introduce CRC Macrodissect AI, an advanced solution designed to assist in colorectal cancer tumor content scoring and selecting regions for downstream macrodissection.

CRC Macrodissect AI and Breast HER2 AI Sneak Peek Read More »

Scroll to Top